methylphenidate hydrochloride
Current shortage
The TGA records this medicine as being in shortage now. A shortage often affects some brands, strengths or pack sizes and not others, so a supply of the medicine may still be available. Your pharmacist can tell you what is in stock and what alternatives exist.
The TGA has assessed this shortage as medium impact, meaning some people may need to change brand, strength or product while it lasts.
11 product records on the Australian Register of Therapeutic Goods, listed in full below. The TGA last updated this information on 8 October 2026. Not medical advice.
The TGA does not publish a reason for a shortage, so Voxsanity cannot show one. Nothing on this page is an explanation of why supply is affected — that information is not in the source and is not inferred here.
This is national information. The TGA records shortages for Australia as a whole. There is no state, territory or pharmacy-level stock information in this data, and Voxsanity cannot tell you whether a particular pharmacy has a medicine in stock. Your pharmacist can.
Products affected
ATTORA LA methylphenidate hydrochloride 60 mg modified release capsule bottle
Capsule, modified release · ARTG 408174
Read the TGA's own shortage record for this product
- Status
- Shortage expected The supplier has told the TGA it expects this medicine to go into shortage. It has not necessarily done so yet. Your pharmacist can tell you what is in stock now.
- Supply
- Available The supplier reports stock is available, though not necessarily at every pharmacy.
- TGA impact rating
- Low impact The TGA has assessed this shortage as low impact, meaning alternatives are generally available and most people can be managed without difficulty.
- Reported from
- 13 November 2026 The TGA's dates span 14 days.
- Expected to be resolved
- 27 November 2026 This is the date the supplier has given the TGA. It can move.
- TGA last updated
- 8 October 2026
What the TGA says is being done
An alternative brand is available.
Quoted from the TGA's own record for this product. Voxsanity has not edited, summarised or interpreted it.
ATTORA LA methylphenidate hydrochloride 40 mg modified release capsule bottle
Capsule, modified release · ARTG 408178
Read the TGA's own shortage record for this product
- Status
- Current shortage The TGA records this medicine as being in shortage now. A shortage often affects some brands, strengths or pack sizes and not others, so a supply of the medicine may still be available. Your pharmacist can tell you what is in stock and what alternatives exist.
- Supply
- Limited Availability The supplier reports limited stock.
- TGA impact rating
- Low impact The TGA has assessed this shortage as low impact, meaning alternatives are generally available and most people can be managed without difficulty.
- Reported from
- 8 October 2026 The TGA's dates span 2 months.
- Expected to be resolved
- 27 November 2026 This is the date the supplier has given the TGA. It can move.
- TGA last updated
- 8 October 2026
What the TGA says is being done
An alternative brand is available.
Quoted from the TGA's own record for this product. Voxsanity has not edited, summarised or interpreted it.
RUBIFEN LA methylphenidate hydrochloride 40 mg modified release capsules blister pack
Capsule, hard · ARTG 362230
Read the TGA's own shortage record for this product
- Status
- Current shortage The TGA records this medicine as being in shortage now. A shortage often affects some brands, strengths or pack sizes and not others, so a supply of the medicine may still be available. Your pharmacist can tell you what is in stock and what alternatives exist.
- Supply
- Unavailable The supplier reports no stock is available.
- TGA impact rating
- Medium impact The TGA has assessed this shortage as medium impact, meaning some people may need to change brand, strength or product while it lasts.
- Reported from
- 13 May 2025 The TGA's dates span 18 months.
- Expected to be resolved
- 31 October 2026 This is the date the supplier has given the TGA. It can move.
- TGA last updated
- 23 April 2025
What the TGA says is being done
Alternative brands are available. An updated TGA web statement is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products
Quoted from the TGA's own record for this product. Voxsanity has not edited, summarised or interpreted it.
RUBIFEN LA methylphenidate hydrochloride 60 mg modified release capsules blister pack
Capsule, hard · ARTG 362234
Read the TGA's own shortage record for this product
- Status
- Current shortage The TGA records this medicine as being in shortage now. A shortage often affects some brands, strengths or pack sizes and not others, so a supply of the medicine may still be available. Your pharmacist can tell you what is in stock and what alternatives exist.
- Supply
- Unavailable The supplier reports no stock is available.
- TGA impact rating
- Medium impact The TGA has assessed this shortage as medium impact, meaning some people may need to change brand, strength or product while it lasts.
- Reported from
- 18 April 2025 The TGA's dates span 18 months.
- Expected to be resolved
- 31 October 2026 This is the date the supplier has given the TGA. It can move.
- TGA last updated
- 23 April 2025
What the TGA says is being done
Alternative brands are available. An updated TGA web statement is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products
Quoted from the TGA's own record for this product. Voxsanity has not edited, summarised or interpreted it.
METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 27 mg modified release tablet bottle
Tablet, modified release · ARTG 370911
Read the TGA's own shortage record for this product
- Status
- Discontinued The supplier has told the TGA it is permanently stopping supply of this product in Australia. This is not a temporary shortage. Other brands or strengths of the same medicine may still be available, and your doctor or pharmacist can advise on what to do next.
- Supply
- Reduction in supply until supply is exhausted The supplier reports reduced stock, which will run out and not be replaced.
- TGA impact rating
- Low impact The TGA has assessed this shortage as low impact, meaning alternatives are generally available and most people can be managed without difficulty.
- Reported from
- 31 March 2027
- Expected to be resolved
- The TGA does not publish an end date for this record (it records "Unknown"). Voxsanity does not estimate one.
- TGA last updated
- 29 September 2026
What the TGA says is being done
Alternative brands are available. An updated TGA web statement is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products
Quoted from the TGA's own record for this product. Voxsanity has not edited, summarised or interpreted it.
METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 18 mg modified release tablet bottle
Tablet, modified release · ARTG 370912
Read the TGA's own shortage record for this product
- Status
- Discontinued The supplier has told the TGA it is permanently stopping supply of this product in Australia. This is not a temporary shortage. Other brands or strengths of the same medicine may still be available, and your doctor or pharmacist can advise on what to do next.
- Supply
- Reduction in supply until supply is exhausted The supplier reports reduced stock, which will run out and not be replaced.
- TGA impact rating
- Low impact The TGA has assessed this shortage as low impact, meaning alternatives are generally available and most people can be managed without difficulty.
- Reported from
- 31 March 2027
- Expected to be resolved
- The TGA does not publish an end date for this record (it records "Unknown"). Voxsanity does not estimate one.
- TGA last updated
- 29 September 2026
What the TGA says is being done
Alternative brands are available. An updated TGA web statement is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products
Quoted from the TGA's own record for this product. Voxsanity has not edited, summarised or interpreted it.
METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 54 mg modified release tablet bottle
Tablet, modified release · ARTG 370899
Read the TGA's own shortage record for this product
- Status
- Discontinued The supplier has told the TGA it is permanently stopping supply of this product in Australia. This is not a temporary shortage. Other brands or strengths of the same medicine may still be available, and your doctor or pharmacist can advise on what to do next.
- Supply
- Reduction in supply until supply is exhausted The supplier reports reduced stock, which will run out and not be replaced.
- TGA impact rating
- Low impact The TGA has assessed this shortage as low impact, meaning alternatives are generally available and most people can be managed without difficulty.
- Reported from
- 15 October 2026
- Expected to be resolved
- The TGA does not publish an end date for this record (it records "Unknown"). Voxsanity does not estimate one.
- TGA last updated
- 29 September 2026
What the TGA says is being done
Alternative brands are available. An updated TGA web statement is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products
Quoted from the TGA's own record for this product. Voxsanity has not edited, summarised or interpreted it.
METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 36 mg modified release tablet bottle
Tablet, modified release · ARTG 370900
Read the TGA's own shortage record for this product
- Status
- Discontinued The supplier has told the TGA it is permanently stopping supply of this product in Australia. This is not a temporary shortage. Other brands or strengths of the same medicine may still be available, and your doctor or pharmacist can advise on what to do next.
- Supply
- Reduction in supply until supply is exhausted The supplier reports reduced stock, which will run out and not be replaced.
- TGA impact rating
- Low impact The TGA has assessed this shortage as low impact, meaning alternatives are generally available and most people can be managed without difficulty.
- Reported from
- 15 October 2026
- Expected to be resolved
- The TGA does not publish an end date for this record (it records "Unknown"). Voxsanity does not estimate one.
- TGA last updated
- 29 September 2026
What the TGA says is being done
Alternative brands are available. An updated TGA web statement is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products
Quoted from the TGA's own record for this product. Voxsanity has not edited, summarised or interpreted it.
RUBIFEN LA methylphenidate hydrochloride 20 mg modified release capsules blister pack
Capsule, hard · ARTG 362231
Read the TGA's own shortage record for this product
- Status
- Shortage resolved The TGA records this shortage as over. Supply reaching individual pharmacies can still take time after a shortage is resolved, so your pharmacy may not have restocked yet.
- Supply
- Available The supplier reports stock is available, though not necessarily at every pharmacy.
- TGA impact rating
- Medium impact The TGA has assessed this shortage as medium impact, meaning some people may need to change brand, strength or product while it lasts.
- Reported from
- 25 August 2025 The TGA's dates span 12 months.
- Resolved
- 20 August 2026
- TGA last updated
- 25 August 2025
RUBIFEN LA methylphenidate hydrochloride 30 mg modified release capsules blister pack
Capsule, hard · ARTG 362232
Read the TGA's own shortage record for this product
- Status
- Shortage resolved The TGA records this shortage as over. Supply reaching individual pharmacies can still take time after a shortage is resolved, so your pharmacy may not have restocked yet.
- Supply
- Available The supplier reports stock is available, though not necessarily at every pharmacy.
- TGA impact rating
- Medium impact The TGA has assessed this shortage as medium impact, meaning some people may need to change brand, strength or product while it lasts.
- Reported from
- 10 June 2025 The TGA's dates span 16 months.
- Resolved
- 1 October 2026
- TGA last updated
- 23 April 2025
RUBIFEN LA methylphenidate hydrochloride 10 mg modified release capsules blister pack
Capsule, hard · ARTG 362233
Read the TGA's own shortage record for this product
- Status
- Shortage resolved The TGA records this shortage as over. Supply reaching individual pharmacies can still take time after a shortage is resolved, so your pharmacy may not have restocked yet.
- Supply
- Available The supplier reports stock is available, though not necessarily at every pharmacy.
- TGA impact rating
- Medium impact The TGA has assessed this shortage as medium impact, meaning some people may need to change brand, strength or product while it lasts.
- Reported from
- 3 June 2025 The TGA's dates span 15 months.
- Resolved
- 20 August 2026
- TGA last updated
- 23 April 2025
Terms like ARTG, TGA and PBS are explained in the glossary.
Where this comes from
Source: Medicine Shortage Reports Database, Therapeutic Goods Administration (TGA), © Commonwealth of Australia, reproduced with permission. The TGA does not endorse Voxsanity, and nothing here is presented as a TGA view. Shortage information is free for everyone on this site, with no account and no subscription.
Every product listed above links to the TGA's own shortage record for that product. The TGA's register is organised by product rather than by medicine, so there is no single TGA page covering methylphenidate hydrochloride as a whole; to see them together, open the TGA Medicine Shortage Reports Database and type methylphenidate hydrochloride into its filter box. General information about medicine shortages is on the TGA's medicine shortages page.
Voxsanity last read the register on 16 October 2026.
Not medical advice. Voxsanity republishes public government health data in plain English. Speak to your pharmacist or doctor about your own medicines. Do not stop or change how you take a medicine because of anything on this page.